Similar articles

• Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.

  Adachi K, Numano F. Adachi K, et al. Jpn J Pharmacol. 1977 Feb;27(1):97-103. doi: 10.1254/jjp.27.97. Jpn J Pharmacol. 1977. PMID: 194077
• Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex.

  Palmer GC. Palmer GC. Neuropharmacology. 1976 Jan;15(1):1-7. doi: 10.1016/0028-3908(76)90089-7. Neuropharmacology. 1976. PMID: 176608 No abstract available.
• Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.

  Shimoyama M, Kawai M, Nasu S, Shioji K, Hoshi Y. Shimoyama M, et al. Physiol Chem Phys. 1975;7(2):125-32. Physiol Chem Phys. 1975. PMID: 239431
• [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].

  Nemoz G, Prigent AF. Nemoz G, et al. Ann Pharm Fr. 1984;42(2):99-112. Ann Pharm Fr. 1984. PMID: 6091520 Review. French. No abstract available.
• Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors.

  Ashida S, Sakuma K. Ashida S, et al. Adv Second Messenger Phosphoprotein Res. 1992;25:229-39. Adv Second Messenger Phosphoprotein Res. 1992. PMID: 1313259 Review. No abstract available.